RedHill Biopharma reported $-1.31 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Cara Therapeutics USD -0.59 4.45 Sep/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
Cronos Group USD 0.02 0.05 Dec/2025
RedHill Biopharma USD -1.31 33.38 Jun/2024